📰 Efficacy Study News
Page 3 - Efficacy Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Efficacy Study. Real-time updates on events, politics, business and more.
December 8, 2022
Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.TORONTO, ON / ACCESSWIRE / December 8
November 16, 2022
FREMONT, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology
November 14, 2022
Late in 2021, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's Recombinant
November 2, 2022
Pfizer announced its maternal vaccine against RSV to be almost 82% effective in protecting infants for the first 90 days of life against severe illness.
October 17, 2022
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) said it has presented a poster at the 2022 National Organization for Rare Disorders (NORD) Rare Diseases and...
September 23, 2022
Investegate announcements from AstraZeneca PLC, Ultomiris approved in EU for gMG
September 23, 2022
23.09.2022 - FREEMONT, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) - via NewMediaWire - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced ... Seite 1
September 1, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
August 31, 2022
31.08.2022 - DEVON, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) - Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced the acceptance ... Seite 1
August 31, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires